We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
Cap. Flow
+$1.82B
Cap. Flow %
5.13%
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$172M
2
HON icon
Honeywell
HON
+$160M
3
MSFT icon
Microsoft
MSFT
+$159M
4
AMZN icon
Amazon
AMZN
+$91M
5
TSLA icon
Tesla
TSLA
+$89.8M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.3M
2
STMP
Stamps.com, Inc.
STMP
+$42.3M
3
MGNI icon
Magnite
MGNI
+$36.1M
4
MXIM
Maxim Integrated Products
MXIM
+$34.8M
5
ETSY icon
Etsy
ETSY
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Consumer Discretionary 14.43%
3 Communication Services 10.72%
4 Healthcare 9.96%
5 Financials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVLP
1976
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$40K ﹤0.01%
13,434
+2,165
+19% +$7.28K
LITS
1977
Lite Strategy Inc
LITS
$33.6M
$38K ﹤0.01%
695
-711
-51% -$39.1K
NPKI
1978
NPK International
NPKI
$1.21B
$38K ﹤0.01%
11,575
-11,572
-50% -$32.7K
EGIO
1979
DELISTED
Edgio, Inc. Common Stock
EGIO
$38K ﹤0.01%
400
-411
-51% -$43.3K
INFI
1980
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$38K ﹤0.01%
11,216
-11,492
-51% -$35.4K
DRRX
1981
DELISTED
DURECT Corp
DRRX
$37K ﹤0.01%
2,899
-2,970
-51% -$40.3K
NMTR
1982
DELISTED
9 Meters Biopharma
NMTR
$37K ﹤0.01%
1,431
-1,326
-48% -$31.2K
EMWP
1983
DELISTED
Eros Media World PLC
EMWP
$37K ﹤0.01%
2,036
-2,085
-51% -$39.8K
ORTX
1984
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$36K ﹤0.01%
1,575
+374
+31% +$11.1K
UBX
1985
DELISTED
Unity Biotechnology
UBX
$35K ﹤0.01%
+1,177
New +$41.5K
XERS icon
1986
Xeris Biopharma Holdings
XERS
$1.44B
$35K ﹤0.01%
14,205
+2,280
+19% +$6.62K
ATHX
1987
DELISTED
Athersys, Inc. Common Stock
ATHX
$35K ﹤0.01%
1,050
-1,036
-50% -$39.4K
CALA
1988
DELISTED
Calithera Biosciences, Inc
CALA
$35K ﹤0.01%
792
+127
+19% +$5.48K
CTXR icon
1989
Citius Pharmaceuticals
CTXR
$14.3M
$30K ﹤0.01%
582
-596
-51% -$29.9K
SEEL
1990
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$30K ﹤0.01%
3
-2
-40% -$17.2K
DS
1991
DELISTED
Drive Shack Inc.
DS
$30K ﹤0.01%
10,587
-10,845
-51% -$29.2K
IBIO icon
1992
iBio
IBIO
$71M
$29K ﹤0.01%
55
-57
-51% -$35.5K
TNXP icon
1993
Tonix Pharmaceuticals
TNXP
$157M
– –
0
– –
TRVN
1994
DELISTED
Trevena, Inc.
TRVN
$26K ﹤0.01%
34
-34
-50% -$28.8K
OTLK icon
1995
Outlook Therapeutics
OTLK
$264M
$25K ﹤0.01%
571
-565
-50% -$27.3K
QTNT
1996
DELISTED
Quotient Limited Ordinary Shares
QTNT
$24K ﹤0.01%
251
-258
-51% -$32.2K
NBEV
1997
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$24K ﹤0.01%
17,236
-17,307
-50% -$31.5K
CSLT
1998
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$24K ﹤0.01%
15,579
-15,404
-50% -$30.2K
CARM
1999
DELISTED
Carisma Therapeutics
CARM
$20K ﹤0.01%
1,268
-950
-43% -$45.6K
VYNE icon
2000
VYNE Therapeutics
VYNE
$340K
$15K ﹤0.01%
+611
New +$23.7K
78 79
80
81 82

Similar funds

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

ProShare Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.

  • ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
  • ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
  • ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
  • ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
  • ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
  • ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
  • ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.